A US Food and Drug Administration panel has rejected the use of MDMA as a treatment for post-traumatic stress disorder.
Panelists expressed concern about the quality of the clinical trials used with the drug commonly known as ecstasy or molly.
Ira Spitzer reports.
IN: The MDMA vote...
OUT: SOC
DUR: 41